Nikki H Stricker, John L Stricker, Ryan D Frank, Winnie Z Fan, Teresa J Christianson, Jay S Patel, Aimee J Karstens, Walter K Kremers, Mary M Machulda, Julie A Fields, Jonathan Graff-Radford, Clifford R Jack, David S Knopman, Michelle M Mielke, Ronald C Petersen
{"title":"Stricker学习跨度标准有效性:一种远程自我管理、多设备兼容的数字词表记忆测量方法在区分淀粉样蛋白和tau PET定义的生物标志物组别方面显示出与亲临现场的听觉言语学习测试相似的能力。","authors":"Nikki H Stricker, John L Stricker, Ryan D Frank, Winnie Z Fan, Teresa J Christianson, Jay S Patel, Aimee J Karstens, Walter K Kremers, Mary M Machulda, Julie A Fields, Jonathan Graff-Radford, Clifford R Jack, David S Knopman, Michelle M Mielke, Ronald C Petersen","doi":"10.1017/S1355617723000322","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>The Stricker Learning Span (SLS) is a computer-adaptive digital word list memory test specifically designed for remote assessment and self-administration on a web-based multi-device platform (Mayo Test Drive). We aimed to establish criterion validity of the SLS by comparing its ability to differentiate biomarker-defined groups to the person-administered Rey's Auditory Verbal Learning Test (AVLT).</p><p><strong>Method: </strong>Participants (<i>N</i> = 353; mean age = 71, SD = 11; 93% cognitively unimpaired [CU]) completed the AVLT during an in-person visit, the SLS remotely (within 3 months) and had brain amyloid and tau PET scans available (within 3 years). Overlapping groups were formed for 1) those on the Alzheimer's disease (AD) continuum (amyloid PET positive, A+, <i>n</i> = 125) or not (A-, <i>n</i> = 228), and those with biological AD (amyloid and tau PET positive, A+T+, <i>n</i> = 55) vs no evidence of AD pathology (A-T-, <i>n</i> = 195). Analyses were repeated among CU participants only.</p><p><strong>Results: </strong>The SLS and AVLT showed similar ability to differentiate biomarker-defined groups when comparing AUROCs (<i>p</i>'s > .05). In logistic regression models, SLS contributed significantly to predicting biomarker group beyond age, education, and sex, including when limited to CU participants. Medium (A- vs A+) to large (A-T- vs A+T+) unadjusted effect sizes were observed for both SLS and AVLT. Learning and delay variables were similar in terms of ability to separate biomarker groups.</p><p><strong>Conclusions: </strong>Remotely administered SLS performed similarly to in-person-administered AVLT in its ability to separate biomarker-defined groups, providing evidence of criterion validity. Results suggest the SLS may be sensitive to detecting subtle objective cognitive decline in preclinical AD.</p>","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":null,"pages":null},"PeriodicalIF":4.6000,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10756923/pdf/","citationCount":"0","resultStr":"{\"title\":\"Stricker Learning Span criterion validity: a remote self-administered multi-device compatible digital word list memory measure shows similar ability to differentiate amyloid and tau PET-defined biomarker groups as in-person Auditory Verbal Learning Test.\",\"authors\":\"Nikki H Stricker, John L Stricker, Ryan D Frank, Winnie Z Fan, Teresa J Christianson, Jay S Patel, Aimee J Karstens, Walter K Kremers, Mary M Machulda, Julie A Fields, Jonathan Graff-Radford, Clifford R Jack, David S Knopman, Michelle M Mielke, Ronald C Petersen\",\"doi\":\"10.1017/S1355617723000322\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>The Stricker Learning Span (SLS) is a computer-adaptive digital word list memory test specifically designed for remote assessment and self-administration on a web-based multi-device platform (Mayo Test Drive). We aimed to establish criterion validity of the SLS by comparing its ability to differentiate biomarker-defined groups to the person-administered Rey's Auditory Verbal Learning Test (AVLT).</p><p><strong>Method: </strong>Participants (<i>N</i> = 353; mean age = 71, SD = 11; 93% cognitively unimpaired [CU]) completed the AVLT during an in-person visit, the SLS remotely (within 3 months) and had brain amyloid and tau PET scans available (within 3 years). Overlapping groups were formed for 1) those on the Alzheimer's disease (AD) continuum (amyloid PET positive, A+, <i>n</i> = 125) or not (A-, <i>n</i> = 228), and those with biological AD (amyloid and tau PET positive, A+T+, <i>n</i> = 55) vs no evidence of AD pathology (A-T-, <i>n</i> = 195). Analyses were repeated among CU participants only.</p><p><strong>Results: </strong>The SLS and AVLT showed similar ability to differentiate biomarker-defined groups when comparing AUROCs (<i>p</i>'s > .05). In logistic regression models, SLS contributed significantly to predicting biomarker group beyond age, education, and sex, including when limited to CU participants. Medium (A- vs A+) to large (A-T- vs A+T+) unadjusted effect sizes were observed for both SLS and AVLT. Learning and delay variables were similar in terms of ability to separate biomarker groups.</p><p><strong>Conclusions: </strong>Remotely administered SLS performed similarly to in-person-administered AVLT in its ability to separate biomarker-defined groups, providing evidence of criterion validity. Results suggest the SLS may be sensitive to detecting subtle objective cognitive decline in preclinical AD.</p>\",\"PeriodicalId\":2,\"journal\":{\"name\":\"ACS Applied Bio Materials\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":4.6000,\"publicationDate\":\"2024-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10756923/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ACS Applied Bio Materials\",\"FirstCategoryId\":\"102\",\"ListUrlMain\":\"https://doi.org/10.1017/S1355617723000322\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/6/30 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"MATERIALS SCIENCE, BIOMATERIALS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Bio Materials","FirstCategoryId":"102","ListUrlMain":"https://doi.org/10.1017/S1355617723000322","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/6/30 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}
引用次数: 0
摘要
目的:斯特里克学习跨度(SLS)是一种计算机自适应数字单词表记忆测试,专门设计用于远程评估和基于网络的多设备平台(梅奥测试驱动)上的自我管理。我们的目的是通过比较 SLS 与由个人操作的雷氏听觉言语学习测试(AVLT)在区分生物标志物定义的群体方面的能力,确定 SLS 的标准有效性:参与者(N = 353;平均年龄 = 71,SD = 11;93%认知功能未受损[CU])在亲临现场时完成 AVLT 测试,在 3 个月内完成 SLS 远程测试,并在 3 年内完成脑淀粉样蛋白和 tau PET 扫描。重叠组包括:1)阿尔茨海默病(AD)连续体(淀粉样蛋白 PET 阳性,A+,n = 125)或非连续体(A-,n = 228),以及生物 AD(淀粉样蛋白和 tau PET 阳性,A+T+,n = 55)与无 AD 病理证据(A-T-,n = 195)。结果显示,SLS和AVLT的结果显示,SLS和AVLT的结果均为阳性:结果:在比较 AUROCs 时,SLS 和 AVLT 在区分生物标记物定义的组别方面表现出相似的能力(P>0.05)。在逻辑回归模型中,除年龄、教育程度和性别外,SLS 对预测生物标志物组别也有显著作用,包括在仅限于 CU 参与者的情况下。在 SLS 和 AVLT 中都观察到了中等(A- vs A+)到较大(A-T- vs A+T+)的未调整效应大小。学习和延迟变量在区分生物标志物组别方面的能力相似:远程管理的 SLS 与亲自管理的 AVLT 在区分生物标志物定义的组别方面表现相似,为标准有效性提供了证据。结果表明,SLS可以灵敏地检测出临床前AD患者细微的客观认知能力下降。
Stricker Learning Span criterion validity: a remote self-administered multi-device compatible digital word list memory measure shows similar ability to differentiate amyloid and tau PET-defined biomarker groups as in-person Auditory Verbal Learning Test.
Objective: The Stricker Learning Span (SLS) is a computer-adaptive digital word list memory test specifically designed for remote assessment and self-administration on a web-based multi-device platform (Mayo Test Drive). We aimed to establish criterion validity of the SLS by comparing its ability to differentiate biomarker-defined groups to the person-administered Rey's Auditory Verbal Learning Test (AVLT).
Method: Participants (N = 353; mean age = 71, SD = 11; 93% cognitively unimpaired [CU]) completed the AVLT during an in-person visit, the SLS remotely (within 3 months) and had brain amyloid and tau PET scans available (within 3 years). Overlapping groups were formed for 1) those on the Alzheimer's disease (AD) continuum (amyloid PET positive, A+, n = 125) or not (A-, n = 228), and those with biological AD (amyloid and tau PET positive, A+T+, n = 55) vs no evidence of AD pathology (A-T-, n = 195). Analyses were repeated among CU participants only.
Results: The SLS and AVLT showed similar ability to differentiate biomarker-defined groups when comparing AUROCs (p's > .05). In logistic regression models, SLS contributed significantly to predicting biomarker group beyond age, education, and sex, including when limited to CU participants. Medium (A- vs A+) to large (A-T- vs A+T+) unadjusted effect sizes were observed for both SLS and AVLT. Learning and delay variables were similar in terms of ability to separate biomarker groups.
Conclusions: Remotely administered SLS performed similarly to in-person-administered AVLT in its ability to separate biomarker-defined groups, providing evidence of criterion validity. Results suggest the SLS may be sensitive to detecting subtle objective cognitive decline in preclinical AD.